Apr 17
|
Pfizer (NYSE:PFE) Gets CDC Recommendation to Expand ABRYSVO Vaccine Use for RSV Prevention
|
Apr 17
|
Should You Buy, Hold, or Sell BMY Stock Ahead of Q1 Earnings?
|
Apr 17
|
GSK & PFE's RSV Vaccines Recommended for Use in Adults Aged 50-59
|
Apr 17
|
Pharma Stock Roundup: J&J's Q1 Results, PFE's Obesity Setback
|
Apr 17
|
Trump Tariff Plunge: 3 Phenomenal Stocks to Buy at Bargain Prices Right Now
|
Apr 16
|
ACIP Votes to Expand Recommendation for Pfizer’s RSV Vaccine ABRYSVO® to Include Adults Aged 50 to 59 at Increased Risk of Disease
|
Apr 15
|
Why Pfizer Stock Topped the Market on Tuesday
|
Apr 15
|
Pfizer Halts Obesity Pill Development Amid Safety Concerns
|
Apr 15
|
BofA keeps Neutral on Pfizer after danuglipron failure as core thesis unchanged
|
Apr 15
|
Smaller obesity drugmakers jump after Pfizer scraps weight-loss pill
|
Apr 15
|
NVO, LLY, GPCR & VKTX Stocks Gain Following PFE's Obesity Study Setback
|
Apr 15
|
Is High-Yield Pfizer Stock Still a Buy After Scrapping Its Weight Loss Pill?
|
Apr 15
|
Why Viking Therapeutics, Inc. (VKTX) Skyrocketed On Monday?
|
Apr 14
|
Pfizer hits setback in obesity drug race as GLP-1 trial halts
|
Apr 14
|
Trump Initiates Chips and Drug Probes Ahead of More Tariffs
|
Apr 14
|
Top Analyst Reports for Bank of America, Chevron & Stryker
|
Apr 14
|
Stocks to Watch Monday: Apple, Palantir, Intel, Pfizer
|
Apr 14
|
Sector Update: Health Care Stocks Rise Monday Afternoon
|
Apr 14
|
Dell stock pops, Pfizer halts GLP-1 pill trial, M&T Bank outlook
|
Apr 14
|
Pfizer (NYSE:PFE) Discontinues Danuglipron Development After Safety Review in Study
|